05/06/2026
Your statin brought your LDL down. Your cardiovascular risk did not move.
Here is what your prescription is not fixing.
โ
What statins actually do.
Statins block HMG-CoA reductase in the liver. They reduce LDL production. That is the full scope of the mechanism.
One enzyme. One pathway. Nothing more.
โ
What VLDL is.
VLDL is not made the same way as LDL. It is manufactured by the liver from excess triglycerides โ driven by insulin resistance, refined carbs, and visceral fat.
This is a metabolic process, not a cholesterol process.
โ
The problem statins cannot reach.
Statins target the cholesterol pathway. VLDL comes from the metabolic pathway. Two different factories. One drug.
Statins never touch the root cause of VLDL elevation.
โ
VLDL converts into LDL.
VLDL โ IDL โ LDL in the bloodstream. As long as VLDL stays elevated, your LDL gets continually replenished.
The statin keeps blocking. The metabolic factory keeps producing.
โ
The Indian context.
White rice, maida, excess sugar โ all convert to triglycerides in the liver. VLDL floods the bloodstream. The statin masks the number but not the damage.
โ
What actually fixes VLDL.
โ Fix insulin resistance
โ Reduce refined carbohydrates
โ Resistance training
โ Manage visceral fat
These are the levers. Statins do not pull any of them.
โ
The missing conversation.
Most reports stop at LDL. Ask for:
โ VLDL
โ Triglycerides
โ TG:HDL ratio
โ Fasting insulin
โ
The provocation.
A normal LDL on a statin with high VLDL is not a win. It is a managed risk with an unmanaged root.
This is why patients on statins still have cardiovascular events.
โ
Comment โCONSULTโ to book a discovery call.
Connect ๐ค Ziathlon
www.ziathlon.com
โ